Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | -0.54% | -5.61% | -7.04% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.04% | 32.14M | |
+26.83% | 89.91B | |
-26.09% | 73.26B | |
+1.62% | 26.92B | |
-9.85% | 17.27B | |
-0.14% | 16.9B | |
-0.39% | 15.26B | |
+75.62% | 13.51B | |
+83.01% | 13.51B | |
-25.96% | 12.8B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Transcript : Exagen Inc., Q4 2023 Earnings Call, Mar 18, 2024